BIOCEPT INC (BIOC)

US09072V6002 - Common Stock

0.4349  -0.07 (-13.05%)

After market: 0.39 -0.04 (-10.32%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
28.13M25.86M61.25M27.46M5.53M
Cost Of Goods
39.79M28.44M37.76M21.34M10.98M
Gross Profit
-11.67M-2.58M23.48M6.12M-5.45M
Operating Expenses
43.69M29.40M25.89M21.59M17.61M
Research and Development
8.98M6.16M4.96M5.22M4.70M
Selling, General, and Administrative Expenses
34.71M23.24M20.93M16.37M12.91M
Operating Income
-55.35M-31.98M-2.41M-15.47M-23.06M
Interest Income/Expense
-464.00K-316.00K-290.00K-240.00K-250.00K
Other Income/Expense
N/A87.00K0.00-2.10M-1.83M
Income Before Taxes
-53.11M-32.21M-2.70M-17.81M-25.14M
Income Tax
-125.00K-125.00K125.00K0.000.00
Net Income
-52.99M-32.09M-2.82M-17.81M-25.26M
EBITDA
-53.52M-30.33M-879.00K-14.38M-22.13M
 
Per Share Data
EPS Diluted Total Ops
-90.31-56.78-5.73-1.50-12.20
Non GAAP EPS
N/A-43.07-0.10-1.89N/A
 
Statistics
Gross Profit Margin
-41.48%-9.99%38.34%22.29%-98.55%
Profit Margin
-188.38%-124.09%-4.61%-64.86%-456.78%
Operating Profit Margin
-196.79%-123.69%-3.93%-56.34%-417.00%

All data in USD

Charts